Company
ChinaHybio Pharmaceutical (Wuhan) Co., Ltd., Wuhan, China – FDA Inspections
Inspection records and compliance data for Hybio Pharmaceutical (Wuhan) Co., Ltd. in Wuhan, Unknown. 2 FDA inspections on record, last inspected November 29, 2024.
Company Profile
This profile covers Hybio Pharmaceutical (Wuhan) Co., Ltd. based in Wuhan, Unknown, China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected September 1, 2023. Last inspected November 29, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 29, 2024 | Not classified | Human Drugs | 1258283 |
| September 1, 2023 | Not classified | Human Drugs | 1221282 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Hybio Pharmaceutical (Wuhan) Co., Ltd.
FEI Number
3016069760
Address
9 Linkong West Street, Hengdian Street, Huangpi District Unknown, Wuhan, Unknown, China
Country
China
ID: 39005794-b200-4576-995c-08949aa0bfb7